Dear Colleagues,

We cordially invite you to join us at the 2nd International Electronic Conference on Medicinal Chemistry and Pharmaceutics (ECMC-P 2026), sponsored by MDPI’s open access journals Pharmaceuticals and Pharmaceutics.

This platform seeks to provide a forum for discussion for scientists from around the world to share recent developments and innovative ideas in medicinal chemistry and pharmaceutics. This will allow students, researchers, and experts to share their latest theories, results, models, and applications within this multidisciplinary area of knowledge. This is an entirely online conference that will be held in November at https://sciforum.net/event/ECMC-P2026. No registration fee will be charged to participants, and an added advantage is the lack of cost for flights, hotels, etc.

The conference will be organized around the aims and scope of the journals Pharmaceuticals and Pharmaceutics, which includes the following general topics:

S1. Invited Lectures;
S2. General;
S3. New Small Molecules as Drug Candidates;
S4. Natural Products and Biopharmaceuticals;
S5. Novel Methodologies and AI;
S6. New Modalities in Drug Discovery;
S7. Radiopharmaceuticals;
S8. Nanomedicine and Nanotechnology;
S9. Formulation, Drug Delivery, and Controlled Release;
S10. Biopharmaceutics, Disposition, Pharmacokinetics and Pharmacodynamics.

Researchers are invited to provide a short abstract (250 words maximum without figures and references) online, through this link from now until 10 September 2026.

Each participant can submit only one abstract as a presenting author and a maximum of three submissions per research group (each author can only sign a maximum of three contributions). An institutional email address is required to submit contributions. The authors will be notified in October 2026 about the acceptance status of their abstract(s). At that point, they will be asked to present their work (in English) as a poster, a slideshow, or a video using the templates provided by the conference (see Instructions for Authors). All accepted submissions will be displayed online and be open for discussion, comments, and questions during the entire conference at conference website on 1–30 November 2026.

All participants will be invited to submit a full paper describing their work. The papers will be peer-reviewed and, upon acceptance, published in the conference's Special Issue. A 20% discount on the article processing charge will be applied.

The scientific committee will select the most outstanding works, which will be rewarded with grants offered by the sponsoring journals, Pharmaceuticals and Pharmaceutics.

We look forward to engaging in exciting discussions and hearing new ideas and perspectives from experts in the field. All participants are welcome to join the online conference.

Kind regards,

Prof. Dr. Maria Emília Sousa—Interdisciplinary Centre of Marine and Environmental Research (CIIMAR) and University of Porto, Porto, Portugal
Prof. Mary J. Meegan—School of Pharmacy and Pharmaceutical Sciences, Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland
Dr. Alfredo Berzal-Herranz—Instituto de Parasitología y Biomedicina López-Neyra, (IPBLN-CSIC), Spain
Prof. Dr. Thierry Vandamme—Laboratory for the Conception and Application of Bioactive Molecules, Faculty of Pharmacy, University of Strasbourg, France
Prof. Dr. Francisco Javier Otero Espinar—Department of Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Spain

Follow the conference organizer on Social Media